The PCTEX in Badajoz, Spain, Will Host the ‘Biotech Conecta’ Event on December 10th

The Extremadura Science and Technology Park (PCTEX) in Badajoz will host ‘Biotech Conecta: Connecting the Bio Potential of Extremadura’ on December 10th, which aims to consolidate the role of biotechnology as a “development engine” for the region in strategic sectors such as agri-food and health.

Organised by Fundecyt-PCTEx, this meeting seeks to establish the foundations of a dynamic and cohesive regional biotechnology community, capable of addressing the “great global challenges” from Extremadura, as stated by the Regional Government in a press release.

The aim is to focus on biotechnology as a key resource for responding to the “social, technological and environmental challenges that are transforming the economy.”

Extremadura, with its “commitment to research and innovation”, is positioned as a “reference” in the development of high-value bioproducts, such as drugs, probiotics, diagnostic and treatment processes for diseases and sustainable industrial processes, the regional government stresses.

The event’s program will include presentations and sessions to analyse regional positioning in relation to global trends and networking dynamics, with the aim of promoting connections between agents in the biotech ecosystem, with the participation of biotechnology experts from various fields.

Organized by Fundecyt-PCTEx, the event highlights the region’s potential in bioproducts

The central block of the event will be developed with a series of sectorial panels focused on the opportunities and challenges of biotechnology in Extremadura.

Meanwhile, in the agri-food sector, the head of Biotechnology at CTAEx, José Antonio García Barrado, will analyse the regional positioning in relation to agro-biotechnological trends, followed by a presentation on good local biotechnological practices in the agricultural sector.

Regarding the health sector, María Coronada Fernández Calderón, from the Extremadura University Institute for Biosanitary Research (INUBE), will present the region’s potential to address biotechnological trends in the health field, complemented by the researcher at the company Ingulados SL, María Bravo, who will share applied practical cases.

The industrial sector will be the focus of attention with a reflection on the positioning of Extremadura in relation to global trends in industrial biotechnology, with the participation of Jonathan Delgado, from Cicytex, and a review of good practices in this field.

Following a dynamic presentation of initiatives and results of some of the projects in which Fundecyt-PCTEx is involved, work will be done to design the next steps to further connect the biotechnology sector in Extremadura by 2025.

Registration, which is open and free of charge, can be completed through the Fundecyt-PCTEx website, where all the information regarding the event can be consulted. The event is being held with co-financing from the FEDER Extremadura 2021-2027 Programme, within the framework of the TE “Governance of the RIS3 Extremadura 2027 and the EDPs.”

It has the collaboration of the Iberobio project, part of the Interreg VI A Spain-Portugal Program (POCTEP) 2021-2027, in which Extremadura participates through Fundecyt-PCTEx and leads the Business Technology Cluster of Life Sciences of Galicia (Bioga).

__

(Featured image by Pedro Lemos via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in REGIONDIGITAL.com. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.